Autoantibodies against aggrecan in systemic rheumatic diseases

Biochimie

Volumn 88, Issue 7, 2006, Pages 767-773

  Vynios, D H ^a   Tsagaraki, I ^a   Grigoreas, G H A ^a   Samiotaki, M ^b   Panayotou, G ^b   Kyriakopoulou, D ^c   Georgiou, P ^c   Korbakis, D ^a   Panayotou, A ^a   Nanouri, K ^a   Assouti, M ^a   Andonopoulos, A P ^c  

^a School of Health Sciences   (Greece)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Anti aggrecan autoantibodies; ELISA; G2 aggrecan domain; Hyaluronan binding region; Systemic rheumatic diseases

Indexed keywords

AGGRECAN; AUTOANTIBODY; HYALURONIC ACID; PROTEINASE; PROTEOGLYCAN; LECTIN; PROTEOCHONDROITIN SULFATE; SCLEROPROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CANCER; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; OSTEOARTHRITIS; RHEUMATIC DISEASE; SOLID; SYSTEMIC DISEASE; WESTERN BLOTTING; ANALYSIS OF VARIANCE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; NANOTECHNOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; ANALYSIS OF VARIANCE; AUTOANTIBODIES; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LECTINS, C-TYPE; MASS SPECTROMETRY; MIDDLE AGED; NANOTECHNOLOGY; OSTEOARTHRITIS; PROTEOCHONDROITIN SULFATES; RHEUMATIC DISEASES;

EID: 33746667814     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2006.01.004     Document Type: Article

References (29)

1. Doege K.J., Sasaki M., Kimura T., and Yamada Y. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. J. Biol. Chem. 266 (1991) 894-902
2. Hardingham T.E., and Fosang A.J. Proteoglycans: many forms and many functions. FASEB J. 6 (1992) 861-869
3. Kjellen L., and Lindahl U. Proteoglycans; structures and interactions. Annu. Rev. Biochem. 60 (1991) 443-475
4. Heinegard D., and Hascall V.C. Aggregation of cartilage proteoglycans. 3. Characteristics of the proteins isolated from trypsin digests of aggregates. J. Biol. Chem. 249 (1974) 4250-4256
5. Fischer D.C., Kolbe-Busch S., Stocker G., Hoffman A., and Haubeck H.D. Development of enzyme immunoassays specific for KS- and core protein-epitopes of the large aggregating proteoglycan from human articular cartilage. Eur. J. Clin. Chem. Clin. Biochem. 32 (1994) 285-291
6. Thonar E.J., Masuda K., Hauselmann H.J., Uebelhart D., Lenz M.E., and Manicourt D.H. Keratan sulfate in body fluids in joint disease. Acta Orthop. Scand. Suppl. 266 (1995) 103-106
7. Mansson B., Carey D., Alini M., Ionescu M., Rosenberg L.C., Poole A.R., Heinegard D., and Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J. Clin. Invest. 95 (1995) 1071-1077
8. Bleasel J.F., Poole A.R., Heinegard D., Saxne T., Holderbaum D., Ionescu M., Jones P., and Moskowitz R.W. Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation. Arthritis Rheum. 42 (1999) 39-45
9. Matyas J.R., Atley L., Ionescu M., Eyre D.R., and Poole A.R. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum. 50 (2004) 543-552
10. Kim T.-H., Stone M., Payne U., Zhang X., Ionescu M., Lobanok T., King L., Poole A.R., and Inman R.D. Cartilage biomarkers in ankylosing spondylitis. Relationship to clinical variables and treatment response. Arthritis Rheum. 52 (2005) 885-891
11. Cs-Szabo G., Roughley J.P., Plaas H.K.A., and Glant T.T. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum. 38 (1995) 660-668
12. Lohmander L.S., Ionescu M., Jugessur H., and Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum. 42 (1999) 534-544
13. Zhang Y., Guerassimov A., Leroux J.Y., Cartman A., Webber C., Lalic R., de Miguel E., Rosenberg L.C., and Poole A.R. Arthritis induced by proteoglycan aggrecan G1 domain in balb/c mice. J. Clin. Invest. 101 (1998) 1678-1686
14. Mikecz K., Brennan F.R., Kim J.H., and Glant T.T. The role of adhesion molecules in the development of autoimmune arthritis. Scand. J. Rheumatol. Suppl. 101 (1995) 99-106
15. Kaplan C., Valdez C.J., Chandrasekaran R., Eibel H., Mikecz K., Glant T.T., and Finnegan A. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibodies isotypes and arthritis. Arthritis Res. 4 (2002) 54-58
16. Karopoulos C., Rowly J.M., Ilic Z.M., and Handley J.C. Presence of antibodies to native G1 domain of aggrecan core protein in synovial fluids from patients with various joint diseases. Arthritis Rheum. 39 (1996) 1990-1997
17. Polgar A., Falus A., Koo E., Ujfalussy I., Sesztak M., Szuts I., Konrad K., Hodinka L., Bene E., Meszaros G., Ortutay Z., Farkas E., Paksy A., and Buzas E.I. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) 42 (2003) 522-527
18. Grigoreas G.H., Anagnostides S.T., and Vynios D.H. A solid-phase assay for the quantitative analysis of hyaluronic acid at the nanogram level. Anal. Biochem. 320 (2003) 179-184
19. Vynios D.H., Morgelin M., Papageorgakopoulou N., Tsilemou A., Spyracopoulou G., Zafira M.-E., and Tsiganos C.P. Polydispersity and heterogeneity of squid cranial cartilage proteoglycans as assessed by immunochemical methods and electron microscopy. Biochimie 82 (2000) 773-782
20. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315-324
21. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum. 25 (1982) 1271-1277
22. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 36 (1993) 340-347
23. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 34 (1991) 1218-1227
24. Van Riel P.L.C.M. Provisional guidelines for measuring disease activity in RA clinical trials. Editorial. Br. J. Rheumatol. 31 (1992) 793-794
25. Gladman D.D., Ibañez D., and Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 29 (2000) 288-291
26. Vynios D.H., Vamvakas S.S., Kalpaxis D.L., and Tsiganos C.P. Aggrecan immobilization onto polystyrene plates through electrostatic interactions with permine. Anal. Biochem. 260 (1998) 64-70
27. Morrissey J.H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117 (1981) 307-310
28. Gatlin L.C., Kleemann R.G., Hays G.L., Link J.A., and Yates III R.J. Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectroscopy. Anal. Biochem. 263 (1998) 93-101
29. Zou J., Appel H., Rudwaleit M., Thiel A., and Sieper J. Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis. Ann. Rheum. Dis. 64 (2005) 722-729